This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ameriso, S. F. Articles by Spence, J. D. Search for Related Content PubMed PubMed Citation Articles by Ameriso, S. F. Articles by Spence, J. D. Related Collections Pathophysiology Risk Factors Carotid Stenosis Mechanism of atherosclerosis/growth factors

(Stroke. 2001;32:385.)
© 2001 American Heart Association, Inc.

Original Contributions

Detection of Helicobacter pylori in Human Carotid Atherosclerotic Plaques

Sebastián F. Ameriso, MD; Esteban A. Fridman, MD; Ramón C. Leiguarda, MD Gustavo E. Sevlever, MD

From the Departments of Neurology (S.F.A., E.A.F., R.C.L.) and Neuropathology (G.E.S.), Institute for Neurological Research (FLENI), Buenos Aires, Argentina.

	Abstract

Top Abstract Introduction Subjects and Methods Results Discussion References Introduction  References

 
Background and Purpose—Several lines of evidence point toward a relationship between infection and atherosclerotic vascular disease. Thus, infection and inflammation often precede ischemic neurological events. Transient alterations in coagulation and direct arterial invasion by certain microorganisms have been reported. Helicobacter pylori infection is the major cause of peptic ulcer disease and appears to be a risk factor for ischemic cerebrovascular disease. However, in contrast to other chronic infectious agents, H pylori has not been consistently isolated from atherosclerotic lesions.

Methods—We investigated the presence of H pylori in 38 atherosclerotic plaques obtained at carotid endarterectomy by using morphological and immunohistochemical techniques and a highly sensitive polymerase chain reaction method. We performed immunohistochemical detection of intercellular adhesion molecule-1, a marker related to inflammatory cell response. We also examined 7 carotid arteries obtained at autopsy from subjects without carotid atherosclerosis.

Results—H pylori DNA was found in 20 of 38 atherosclerotic plaques. Ten of the H pylori DNA–positive plaques also showed morphological and immunohistochemical evidence of H pylori infection. None of 7 normal carotid arteries was positive for H pylori. Intercellular adhesion molecule-1 was expressed in 75% of H pylori–positive plaques and in 22% of H pylori–negative plaques. The presence of the microorganism was associated with male sex but was independent of age, vascular risk factor profile, and prior neurological symptoms.

Conclusions—H pylori is present in a substantial number of carotid atherosclerotic lesions and is associated with features of inflammatory cell response. This study provides additional evidence of the relationship between H pylori infection and atherosclerotic disease.

Key Words: atherosclerosis • carotid artery diseases • Helicobacter pylori • infection • intercellular adhesion molecule-1

	Introduction

Top Abstract Introduction Subjects and Methods Results Discussion References Introduction  References

 
In recent years, numerous investigations have established an association between infectious and inflammatory processes and the occurrence of vascular disease.^{1 2 3 4 5 6 7 8}

Expression of adhesion molecules in the endothelium and smooth muscle is a key component of the inflammatory response in atherosclerotic lesions.⁹ Increased endothelial inflammatory activity reflected by enhanced expression of intercellular adhesion molecule-1 (ICAM-1) and tumor necrosis factor- is common in human carotid atherosclerotic plaques, and its role in the occurrence of neurological symptoms is under active research.^{9 10 11 12}

Infectious processes may act through both systemic effects and direct arterial invasion.¹ Infection by Chlamydia pneumoniae, cytomegalovirus, Helicobacter pylori, herpes simplex virus types 1 and 2, and hepatitis A virus appear to be more prevalent in individuals with systemic atherosclerosis.^{13 14 15 16 17 18 19 20 21} Acute infection frequently precedes myocardial and cerebral infarction, suggesting a role as an independent risk factor that may trigger the ischemic event.^{22 23 24 25 26 27 28} It is not unlikely that transient alterations in coagulation pathways and other as yet poorly understood processes mediate the association between infection and the onset of acute vascular episodes.^{26 28}

Chronic infection may be implicated in the pathophysiological cascade leading to atherosclerosis.^{1 29} A direct role of microorganisms in the development of atherosclerosis is suggested by the presence of C pneumoniae, cytomegalovirus, and herpes simplex virus in diseased vessels.^{30 31 32 33} These agents can be found in atherosclerotic lesions of coronary and carotid arteries but appear to be absent in normal vessels. The role of these microorganisms in the initiation and progression of atherosclerosis and potential therapeutic implications are under investigation.

The Gram-negative curved bacillus H pylori colonizes the gastrointestinal system in approximately half of all adults and is associated with chronic gastritis, peptic ulcer disease, and gastric cancer.^{34 35 36 37} The relationship between this microorganism and other disorders is currently being debated.^{38 39} Several reports have implicated H pylori infection in coronary artery disease, especially when more virulent strains are involved (ie, the Cag A strain).⁴⁰ Seropositivity for H pylori has been postulated to be an independent risk factor for ischemic stroke.⁴¹ Several potential mechanisms for the association are under research.^{38 39 42 43 44 45 46 47} Although serological evidence relates H pylori infection with atherosclerotic disease, the bacterium has not yet been isolated from atherosclerotic lesions^{48 49 50} except for a single study published recently in abstract form.⁵¹

The objective of the present study was to search for the presence of H pylori in atherosclerotic plaques from patients undergoing carotid endarterectomy by use of immunohistochemical methods and a sensitive polymerase chain reaction (PCR) technique.

	Subjects and Methods

Top Abstract Introduction Subjects and Methods Results Discussion References Introduction  References

 
The investigation was approved by the institutional ethics committee. We searched for the presence of H pylori in 38 consecutive carotid artery specimens obtained during endarterectomy in patients with atherosclerotic lesions producing severe stenosis of the vessel. A detailed medical history was obtained for every subject; this was followed by physical and neurological examinations. Patients who had experienced a transient ischemic attack or stroke in the territory of the operated artery within the last 180 days were considered symptomatic. We also examined 7 carotid arteries of autopsy material from subjects without carotid atherosclerosis.

Specimens were fixed in 10% neutral buffered formalin and subsequently decalcified in formic acid when required. All samples were routinely processed, paraffin-embedded, and cut serially to expose coronal planes of the carotid artery and atheromatous plaque. Several sections were prepared from each specimen for the following: hematoxylin and eosin, elastica van Gieson, PAS, Giemsa, and immunohistochemical staining. Morphological evaluation included the investigation of inflammatory mononuclear cells and the identification of bacteria in the luminal or parietal area. The following antibodies and dilutions were used for immunohistochemistry: factor VIII–von Willebrand at 1:100 (polyclonal rabbit antibody, Dako Corp), CD31 at 1:50 (PECAM, clone 1A10, Novocastra), CD54 at 1:50 (ICAM-1, Dako Corp), CD34 at 1:100 (clone QBEnd/10 at 1:100, BioGenex), and H pylori at 1:100 (polyclonal rabbit antibody NCL-HPp, Novocastra). After deparaffinization, sections were microwaved in 10 mmol/L sodium citrate buffer at pH 6.0 for 10 minutes and incubated with the antibodies. Sections incubated with normal mouse or rabbit IgG at the same dilutions served as negative controls. As a second step, biotinylated horse anti-mouse or goat anti-rabbit IgG (Vector Laboratories Inc) was applied and detected by use of the ABC Elite kit (Vector Laboratories Inc) with diaminobenzidine as substrate. Formalin-fixed paraffin-embedded gastric biopsies with well-characterized H pylori gastritis were used as positive controls. Endothelial preservation was assessed by immunohistochemical detection (avidin-biotin method) for CD34, CD31, and factor VIII–von Willebrand factor. Immunodetection for ICAM-1 was evaluated in cases disclosing endothelial markers.

High molecular weight DNA was isolated from formalin-fixed paraffin-embedded tissue according to Wright and Manos.⁵² A PCR technique reported by Lu et al⁵³ was followed. Briefly, the PCR reaction used a set of primers that amplified the gluM gene between positions 784 and 1077, rendering a 294-bp amplification product. H pylori DNA was amplified in a 50 µL reaction mixture containing 10 mmol/L Tris-HCl buffer, pH 8.4, 50 mmol/L KCl, 1.5 mmol/L MgCl₂, 2.5 mmol/L of each deoxynucleoside triphosphate (Pharmacia/LKB), 1 mmol/L of each primer, and 2.5 U of Taq DNA polymerase (GIBCO-BRL). Reaction tubes were placed in a thermal cycler (PTC-200, MJ Research). Initial denaturing was carried out at 95°C for 5 minutes, followed by 35 cycles of amplification consisting of 95°C for 1 minute, 55°C for 1 minute, 72°C for 1 minute, and a final extension cycle of 72°C for 7 minutes. In a separate reaction tube, a second set of primers for the ß-globin gene was incubated with the DNA template and served as a control to monitor the amplification ability of a single copy gene. PCR-amplified DNA was subjected to electrophoresis on a 2% agarose gel containing ethidium bromide. Samples from microbiological cultures were used as positive controls (Figure 1, lane 11).

View larger version (67K): [in this window] [in a new window]   Figure 1. Ethidium bromide–stained 2% agarose gel electrophoresis. Lanes are as follows: 1 to 9, tissue samples; 10, negative control; 11, H pylori–positive control; and M, molecular weight marker 100-bp ladder (Promega).

We performed direct DNA sequencing of PCR products in 5 selected cases to confirm the bacterial origin of H pylori DNA. PCR products were electrophoresed through 2% low-melting-point agarose gels, and expected fragments were localized and excised. DNA was extracted from melted gel slices by using a Wizard PCR Prep kit (Promega) according to the manufacturer’s instructions. The purified DNA was then sequenced directly by use of the ABI 373A DNA Sequencer with an ABI Taq Dye-Deoxy-Terminator Cycle Sequencing Kit (Perkin-Elmer Corp, Applied Biosystems Division). Signals were recorded and then analyzed by use of a Macintosh Quadra 650.

Statistical Methods
Mean and standard deviations for continuous variables and frequency for dichotomous variables were calculated. The Fisher exact probability test (2-tailed) or ² test was used to examine univariate association of categorical variables with H pylori DNA presence and ICAM-1 expression (SAS System Software, version 6.12). The Cox logistic regression model was used for multivariate analysis (BMDP Statistical Software, version 7.0).

	Results

Top Abstract Introduction Subjects and Methods Results Discussion References Introduction  References

 
We studied consecutive patients referred to our institution for carotid endarterectomy. We examined 38 atherosclerotic plaques from 38 subjects (29 men and 9 women) aged 67±9 (mean±SD) years. Hypertension was present in 25 patients; diabetes mellitus, in 10; smoking, in 14; hypercholesterolemia, in 22; and ischemic heart disease, in 13. None of the subjects had a history of chronic gastritis, peptic ulcer disease, or gastric cancer. Fifteen subjects had sustained symptoms consistent with ischemia in the territory of the operated artery (symptomatic patients). Demographic data for the patient population are provided in the Table. Sex, age, and vascular risk factor profile were similar for symptomatic and asymptomatic subjects.

View this table: [in this window] [in a new window]   Table 1. Data for Patients With Positive and Negative H pylori DNA in Carotid Plaques

H pylori DNA was found in atherosclerotic plaques of 20 patients (53%) (Figure 1). Slender, curved, spiral microorganisms were detected on the endothelial surface as well as in subendothelial clefts in 10 of 20 H pylori DNA–positive cases. Subendothelial inflammatory mononuclear cells were observed in these cases. The microorganisms were positively identified as H pylori by specific immunostaining (Figure 2). None of the 7 carotid arteries without atherosclerotic lesions disclosed the presence of H pylori by either PCR or immunostaining.

View larger version (100K): [in this window] [in a new window]   Figure 2. Carotid atherosclerotic plaques (immunostaining for H pylori, original magnification x1000). A, Immunodetection of the bacillus in subendothelial clefts. B, Immunodetection of the bacillus in the endothelial lumina.

Nineteen of 38 atherosclerotic plaques (50%) and none of 7 normal carotid arteries expressed ICAM-1 (Figure 3). Immunohistochemical evidence of ICAM-1 was associated with H pylori DNA detection; ICAM-1 expression was present in 15 of 20 patients (75%) with H pylori DNA and in 4 of 18 patients (22%) without H pylori DNA (P<0.01).

View larger version (116K): [in this window] [in a new window]   Figure 3. Carotid atherosclerotic plaques (immunostaining for ICAM-1, original magnification x1000). Immunodetection of ICAM-1 in the cytoplasm of endothelial cells is shown.

Demographic and clinical features and ICAM-1 expression pattern in patients with H pylori–positive and –negative plaques are depicted in the Table. No differences could be detected in age, vascular risk factor profile, or the presence of neurological symptoms between patients with or without H pylori DNA or ICAM-1 expression in carotid plaques.

Multivariate logistic regression analysis demonstrated that H pylori DNA detection was associated with the immunohistological presence of ICAM-1 (odds ratio 29.3, 95% CI 2.84 to 302.00; P<0.01) and male sex (odds ratio 23.0, 95% CI 1.58 to 333.00; P<0.01).

On the basis of DNA availability, 5 endarterectomy samples were selected for sequencing analysis. The 270-bp sequenced fragment showed no point mutation compared with the H pylori strain J99 used as a control, demonstrating that the PCR 294-bp amplified fragment was specific for H pylori.

	Discussion

Top Abstract Introduction Subjects and Methods Results Discussion References Introduction  References

 
We found H pylori DNA in 53% of carotid atherosclerotic plaques. In half of these cases, the microorganism was also visualized in the lesion by use of specific immunostaining. H pylori was not found in carotid arteries without atherosclerosis. ICAM-1 was expressed more often in plaques with H pylori DNA. The presence of the bacillus was associated with male sex but not with age, prior neurological symptoms, or risk factor profile.

Our findings disagree with most prior work that failed to find H pylori in vascular lesions. Malnick et al⁴⁸ detected no H pylori in carotid endarterectomy samples from 10 male patients. Blasi and colleagues^{49 50} examined material from surgical specimens of patients with aortic abdominal aneurysms but found no evidence of H pylori infection. We used a PCR protocol that amplified the gluM (ureC) gene, proven to be the most sensitive and specific gene for the detection of H pylori in gastric biopsies, compared with protocols that amplify other genes, such as 16S ribosomal RNA, the 26-kDa species-specific antigen gene, the ureA gene, and the random chromosome sequence.⁵³ The sensitivity of this PCR method was assessed by 10-fold serial dilutions of 10 ng to 1 pg purified H pylori DNA. It detected up to 0.1 pg DNA corresponding to 50 microorganisms. Malnick et al⁴⁸ used the 26-kDa species-specific antigen reported to have poor sensitivity; Blasi and colleagues^{49 50} used the urease gene, which, in the same comparative study, was described to provide low sensitivity, which was probably due to sequence polymorphism. Using the urease A gene method, Akyön et al⁵¹ recently reported PCR detection of H pylori DNA in 19.5% of atherosclerotic plaques.

Our findings met the criteria proposed for diagnosis of H pylori infection in gastroduodenal diseases with specificities and predictive values for negative results >90%.⁵⁴ Direct DNA sequencing of PCR products confirmed that the PCR 294-bp amplified fragment was specific for H pylori.

The present study did not establish the mechanism(s) by which H pylori colonizes the carotid lesions. Also, we did not determine whether the bacillus is transiently or permanently present at this site. Although none of the subjects had a diagnosis of chronic gastritis, peptic ulcer disease, or gastric cancer, we cannot completely rule out this possibility. Thus, the presence of H pylori could represent bacteremic seeding from a primary location in the gastrointestinal tract.

Infectious processes appear to be implicated in the occurrence of cerebrovascular disease.^{1 4 14 25 26 27 28 41} The exact nature of the association is not completely elucidated, and at least 3 different scenarios should be considered. First, acute infection may precipitate ischemic events, especially in subjects with vascular risk factors. This effect has been attributed, at least in part, to the transient imbalance of the coagulation pathway toward a prothrombotic status, and other putative mechanisms are under study.^{26 27 28} Second, chronic infection may be responsible for an increase in the atherosclerotic "load." Numerous studies have reported an increased frequency of serological evidence of chronic infection in patients with cerebrovascular disease.^{4 14 41} These findings suggest that the presence of microorganisms in sites remote from the cerebral arteries may produce systemic alterations predisposing to the development or complication of atherosclerotic disease in cerebral vessels.¹ Third, some microorganisms may participate in the atherosclerotic process by their actual presence on the vessel wall. Published studies have established that C pneumoniae, cytomegalovirus, and herpes simplex can be found in atherosclerotic lesions.^{30 31 32 33} The infectious process within the vessel wall may be responsible for the initiation, progression, and/or complication of the atherosclerotic plaque.^{1 2 3}

Our findings support the last hypothesis and contribute to available evidence by demonstrating that H pylori may be present in human carotid atherosclerotic plaques. Furthermore, the higher frequency of ICAM-1 expression in H pylori–positive plaques suggests an association between the presence of the bacillus and vessel inflammation. Interestingly, ICAM-1 is the predominant form among the cell adhesion molecules expressed in response to chronic H pylori gastric infection.⁵⁵

We also found an association between male sex and H pylori DNA in carotid atherosclerotic plaques. The prevalence rate of H pylori seropositivity is similar in males and females.^{56 57} However, duodenal ulcer, gastric metaplasia, and stroke occur more often in males than in females,^{58 59 60} so that certain host or environmental factors may predispose men to a greater risk of developing gastrointestinal disease and atherosclerosis subsequent to H pylori infection.

In conclusion, H pylori is present in a substantial number of human carotid atherosclerotic lesions and is especially associated with those with inflammatory features. Although the present study fails to provide proof of a causal relation between H pylori infection and atherosclerosis, it adds to prior evidence suggesting a relationship between the bacillus and the pathogenesis of vascular disease. Further research may help to establish the role of H pylori infection in the occurrence of cerebrovascular disease and the potential for therapeutic intervention.

	Acknowledgments

 
This study was supported by the Institute for Neurological Research (FLENI), Buenos Aires, Argentina. We thank Juan C. Parodi, MD, and Aldo Bracco, MD, for expert surgical management of our patients, Marcelo Schultz for technical assistance, Liliana Guelfand, PhD, for providing H pylori culture material, and Roderick Muir for help in preparation of the manuscript. PCR studies were performed by María Victoria Preciado, PhD. Statistical assistance was provided by Ricardo Glancszpiegel, PhD.

	Footnotes

 
Reprint requests to Sebastián F. Ameriso, MD, Institute for Neurological Research (FLENI), Montañeses 2325, (1428) Buenos Aires, Argentina.

Received July 11, 2000; revision received October 1, 2000; accepted October 27, 2000.

	References

Top Abstract Introduction Subjects and Methods Results Discussion References Introduction  References

 
1. Epstein SE, Zhon YF, Zhu J. Infection and atherosclerosis: emerging mechanistic paradigms. Circulation. 1999;100:e20–e28.[Abstract/Free Full Text]

2. Ross R. Mechanism of disease: atherosclerosis an inflammatory disease. N Engl J Med. 1999;340:115–126.[Free Full Text]

3. Cook PJ, Lip GYH. Infectious agents and atherosclerotic vascular disease. QJM. 1996;89:727–735.[Abstract]

4. Mattila KJ, Valtonen VV, Nieminen MS, Asikainen S. Role of infection as a risk factor for atherosclerosis, myocardial infarction, and stroke. Clin Infect Dis. 1998;26:719–734.[Medline] [Order article via Infotrieve]

5. Mehta JL, Saldeen TG, Rand K. Interactive role of infection, inflammation and traditional risk factors in atherosclerosis and coronary artery disease. J Am Coll Cardiol. 1998;31:1217–1225.[Abstract/Free Full Text]

6. Dodet B, Plotkin SA. Infection and atherosclerosis. Am Heart J. 1999;138: S417–S418.

7. Roivainen M, Viik-Kajander M, Palosuo T, Toivanen P, Leinonen M, Saikku P, Tenkanen L, Manninen V, Hovi T, Manttari M. Infections, inflammation, and the risk of coronary heart disease. Circulation. 2000;101:252–257.[Abstract/Free Full Text]

8. Muhlestein JB. Bacterial infections and atherosclerosis. J Investig Med. 1998;46:396–402.[Medline] [Order article via Infotrieve]

9. Davies MJ, Gordon JL, Gearing AJ, Pigott R, Woolf N, Katz D, Kyriakopoulos A. The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis. J Pathol. 1993;171:223–229.[Medline] [Order article via Infotrieve]

10. Endres M, Laufs U, Merz H, Kaps M. Focal expression of intercellular adhesion molecule-1 in the human carotid bifurcation. Stroke. 1997;28:77–82.[Abstract/Free Full Text]

11. DeGraba TJ, Siren AL, Penix L, McCarron RM, Hargraves R, Sood S, Pettigrew KD, Hallenbeck JM. Increased endothelial expression of intercellular adhesion molecule-1 in symptomatic versus asymptomatic human carotid atherosclerotic plaque. Stroke. 1998;29:1405–1410.[Abstract/Free Full Text]

12. Ameriso SF, Fridman E, Parodi JC, Bracco A, Leiguarda R, Sevlever G. Morphologic characteristics and expression of intercellular adhesion molecule-1 in carotid plaques of symptomatic and asymptomatic subjects. Neurology. 1999;52:A565. Abstract.

13. Patel P, Mendall MA, Carrington D, Strachan DP, Leatham E, Molineaux N, Levy J, Blakeston C, Seymour CA, Camm AJ, et al. Association of H pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. BMJ. 1995;311:711–714.[Abstract/Free Full Text]

14. Wimmer M, Sandmann-Strupp R, Saikku P, Haberl RL. Association of Chlamydial infection with cerebrovascular disease. Stroke. 1996;27:2207–2210.[Abstract/Free Full Text]

15. Nieto FJ, Adam E, Sorlie P, Farzadegan H, Melnick JL, Comstock GW, Szklo M. Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis. Circulation. 1996;94:922–927.[Abstract/Free Full Text]

16. Adam E, Melnick JL, Probtsfield JL, Petrie BL, Burek J, Bailey KR, McCollum CH, DeBakey ME. High levels of cytomegalovirus antibody in patients requiring vascular surgery for atherosclerosis. Lancet. 1987;2:291–293.[Medline] [Order article via Infotrieve]

17. Thom DM, Grayston JT, Siscovitch DS, Wang SP, Weiss NS, Daling JR. Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. JAMA. 1992;268:68–72.[Abstract/Free Full Text]

18. Rathbone B, Martin D, Stephens J, Thompson JR, Samani NJ. H. pylori seropositivity in subjects with acute myocardial infarction. Heart. 1996;76:308–311.[Abstract/Free Full Text]

19. Sorlie PD, Adam E, Melnick SL, Folsom A, Skelton T, Chambless LE, Barnes R, Melnick JL. Cytomegalovirus/herpesvirus and carotid atherosclerosis: the ARIC study. J Med Virol. 1994;42:33–37.[Medline] [Order article via Infotrieve]

20. Zhu J, Quyyumi A, Norman JE, Csako GA, Epstein SE. Potential role of hepatitis A virus in coronary artery disease. J Am Coll Cardiol. 1999;33(suppl):4A. Abstract.

21. Blum A, Giladi M, Weinberg M, Kaplan G, Pasternack H, Laniado S, Miller H. High anti-cytomegalovirus (CMV) IgG antibody titer is associated with coronary artery disease and may predict post-coronary balloon angioplasty restenosis. Am J Cardiol. 1998;81:866–868.[Medline] [Order article via Infotrieve]

22. Smith M, Little WC. Potential precipitating factors of the onset of myocardial infarction. Am J Med Sci. 1992;303:141–144.[Medline] [Order article via Infotrieve]

23. Mattila KJ. Viral and bacterial infections in patients with acute myocardial infarction. J Intern Med. 1989;225:293–296.[Medline] [Order article via Infotrieve]

24. Spodick DH. Inflammation and the onset of myocardial infarction. Ann Intern Med. 1985;102:699–702.

25. Syrjanen J, Valtonen VV, Iivanainen M, Kaste M, Huttunen JK. Preceding infection as an important risk factor for ischemic brain infarction in young and middle aged patients. BMJ. 1988;296:1156–1160.

26. Ameriso SF, Wong VLY, Quismorio FP, Fisher M. Immunohematologic characteristics of infection-associated cerebral infarction. Stroke. 1991;22:1004–1009.[Abstract/Free Full Text]

27. Macko RF, Ameriso SF, Barndt R, Clough W, Weiner JM, Fisher M. Precipitants of brain infarction: roles of preceding infection/inflammation and recent psychological stress. Stroke. 1996;27:1999–2004.[Abstract/Free Full Text]

28. Grau AJ, Buggle F, Becher H, Zimmermann E, Spiel M, Fent T, Maiwald M, Werle E, Zorn M, Hengel H, et al. Recent bacterial and viral infection is a risk factor for cerebrovascular ischemia: clinical and biochemical studies. Neurology. 1998;50:196–203.[Abstract/Free Full Text]

29. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet. 1997;350:430–436.[Medline] [Order article via Infotrieve]

30. Kuo CC, Shor A, Campbell LA, Fukushi H, Patton DL, Grayston JT. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis. 1993;167:841–849.[Medline] [Order article via Infotrieve]

31. Kuo CC, Grayston JT, Campbell LA, Goo YA, Wissler RW, Beneditt EP. Chlamydia pneumoniae in arteries of young adults. Proc Natl Acad Sci U S A. 1995;92:6911–6914.[Abstract/Free Full Text]

32. Nicholson AC, Hajjar DP. Herpesvirus in atherosclerosis and thrombosis: etiologic agents or ubiquitous bystanders? Arterioscler Thromb Vasc Biol. 1998;18:339–348.[Abstract/Free Full Text]

33. Skowronski E, Mendoza A, Smith S, Jaski B. Detection of cytomegalovirus in paraffin-embedded postmortem coronary artery specimens of heart transplant recipients by the polymerase chain reaction: implications of cytomegalovirus association with graft atherosclerosis. J Heart Lung Transplant. 1993;12:717–723.[Medline] [Order article via Infotrieve]

34. Howden CW. Clinical expression of H. pylori infection. Am J Med. 1996;100:27S–34S.[Medline] [Order article via Infotrieve]

35. Dunn BE, Cohen H, Blaser MJ. H. pylori. Clin Microbiol Rev. 1997;10:720–741.[Abstract]

36. Graham DY, Malaty HM, Evans DG, Evans DJ, Klein PD, Adam E. Epidemiology of H. pylori in an asymptomatic population in the United States: effect of age, race, and socioeconomic status. Gastroenterology. 1991;100:1495–1501.[Medline] [Order article via Infotrieve]

37. Lin JT, Wang JT, Wang TH, Wu MS, Lee TK, Chen CJ. H. pylori infection in a randomly selected population, healthy volunteers, and patients with gastric ulcer and gastric adenocarcinoma: a seroprevalence study in Taiwan. Scand J Gastroenterol. 1993;28:1067–1072.[Medline] [Order article via Infotrieve]

38. Leontiadis G, Sharma V, Howden C. Non-gastrointestinal tract associations of H. pylori infection: what is the evidence?. Arch Intern Med. 1999;159:925–940.[Abstract/Free Full Text]

39. Ekstrom P. Non gastric effects of H. pylori infection: a literature review with respect to non gastric diseases which might be associated with H. pylori infection. Eur J Surg. 1998;582(suppl):32–34.

40. Pasceri V, Cammarota G, Patti G, Cuoco L, Gasbarrini A, Grillo RL, Fedeli G, Gasbarrini G, Maseri A. Association of virulent H. pylori strains with ischemic heart disease. Circulation. 1998;97:1675–1679.[Abstract/Free Full Text]

41. Markus H, Mendall M. H. pylori infection: a risk factor for ischaemic cerebrovascular disease and carotid atheroma. J Neurol Neurosurg Psychiatry. 1998;64:104–107.[Abstract/Free Full Text]

42. Laurila A, Bloigu A, Nayha S, Hassi J, Leinonen M, Saikku P. Association of H. pylori infection with elevated serum lipids. Atherosclerosis. 1999;142:207–210.[Medline] [Order article via Infotrieve]

43. Ellis RW. Infection and coronary heart disease. J Med Microbiol. 1997;46:535–539.[Abstract/Free Full Text]

44. Birnie DH, Holme ER, McKay IC, Hood S, McColl KE, Hillis WS. Association between antibodies to heat shock protein 65 and coronary atherosclerosis: possible mechanism of action of H. pylori and other bacterial infections in increasing cardiovascular risk. Eur Heart J. 1998;19:387–394.[Abstract/Free Full Text]

45. Markle HV. Coronary artery disease associated with H. pylori infection is at least partially due to inadequate folate status. Med Hypotheses. 1997;49:289–292.[Medline] [Order article via Infotrieve]

46. Pellicano R, Broutet N, Ponzetto A, Megraud F. H. pylori: from the stomach to the heart. Eur J Gastroenterol Hepatol. 1999;11:1335–1337.[Medline] [Order article via Infotrieve]

47. Kusters JG, Kuipers EJ. H. pylori and atherosclerosis. Am Heart J. 1999;38: S523–S527.

48. Malnick SD, Goland S, Kaftoury A, Schwarz H, Pasik S, Mashiach A, Sthoeger Z. Evaluation of carotid arterial plaques after endarterectomy for H. pylori infection. Am J Cardiol. 1999;83:1586–1587.[Medline] [Order article via Infotrieve]

49. Blasi F, Denti F, Erba M, Cosentini R, Raccanelli R, Rinaldi A, Fagetti L, Esposito G, Ruberti U, Allegra L. Detection of Chlamydia pneumoniae but not H. pylori in atherosclerotic plaques of aortic aneurysms. J Clin Microbiol. 1996;34:2766–2769.[Abstract]

50. Blasi F, Boman J, Esposito G, Melissano G, Chiesa R, Cosentini R, Tarsia P, Tshomba Y, Betti M, Alessi M, et al. Chlamydia pneumoniae DNA detection in peripheral blood mononuclear cells is predictive of vascular infection. J Infect Dis. 1999;180:2074–2076.[Medline] [Order article via Infotrieve]

51. Akyön Y, Pinar A, Farsak B, Böke E, Günalp A. H. pylori and Chlamydia pneumoniae DNA found in atherosclerotic plaques by polymerase chain reaction. Gut. 1999;45:A89. Abstract.

52. Wright D, Manos M. Sample preparation from paraffin-embedded tissues. In: Innis M, Guelfand D, Sninsky J, White T, eds. PCR Protocols: A Guide to Methods and Applications. San Diego, Calif: Academic Press; 1990:153–158.

53. Lu JJ, Perng CL, Shyu RY, Chen CH, Lou Q, Chong SK, Lee CH. Comparison of five PCR methods for detection of H. pylori DNA in gastric tissues. J Clin Microbiol. 1999;37:772–774.[Abstract/Free Full Text]

54. Andersen LP, Kiilerick S, Pedersen G, Thoreson AC, Jorgensen F, Rath J, Larsen NE, Borup O, Krogfelt K, Scheibel J, et al. An analysis of seven different methods to diagnose Helicobacter pylori infections. Scand J Gastroenterol. 1998;33:24–30.[Medline] [Order article via Infotrieve]

55. Higuchi K, Arakawa T, Uchida T, Nakagawa K, Nakamura S, Matsumoto T, Fukuda T, Kobayashi K, Kuroki T. "In situ" expression of cell adhesion molecules in chronic gastritis with Helicobacter pylori infection. J Clin Gastroenterol. 1997;25: S215–S221.

56. Graham DY, Malaty HM, Evans DG, Evans DJ, Klein PD, Adam E. Epidemiology of H. pylori in an asymptomatic population in the United States: effect of age, race, and socioeconomic status. Gastroenterology. 1991;100:1495–1501.

57. Lin JT, Wang JT, Wang TH, Wu MS, Lee TK, Chen CJ. H. pylori infection in a randomly selected population, healthy volunteers, and patients with gastric ulcer and gastric adenocarcinoma: a seroprevalence study in Taiwan. Scand J Gastroenterol. 1993;28:1067–1072.

58. Chen TS, Chang FY, Lee SD. Smoking and male gender rather than CagA protein are associated with increased risk for duodenal ulcer in H. pylori-infected patients in Taiwan. Dig Dis Sci. 1999;44:2076–2080.[Medline] [Order article via Infotrieve]

59. Wyatt JI, Rathbone BJ, Sobala GM, Shallcross T, Heatley RV, Axon AT, Dixon MF. Gastric epithelium in the duodenum: its association with H. pylori and inflammation. J Clin Pathol. 1990;43:981–986.[Abstract/Free Full Text]

60. Wolf PA, D’Agostino RB. Epidemiology of stroke. In: Barnett HJM, Mohr JP, Stein BM, Yatsu FM, eds. Stroke: Pathophysiology, Diagnosis, and Management. Philadelphia, Pa: Churchill Livingstone; 1998:3–28.

Editorial Comment

J. David Spence, MD, Guest Editor

Stroke Prevention and Atherosclerosis Research Centre, Siebens–Drake Research Institute, London, Ontario, Canada

	Introduction

Top Abstract Introduction Subjects and Methods Results Discussion References Introduction  References

 
Recent studies indicating a relationship between infection,^R1 markers of inflammation,^{R2 R3} and atherosclerotic events and the identification of infectious agents in atherosclerotic plaques have raised hope in the popular press that, like duodenal ulcers, heart attacks and strokes might easily be prevented with antibiotics. These hopes are unlikely to be borne out. Atherosclerosis is multifactorial; there are several hundred proteins involved in the development, growth, and rupture of plaques and the subsequent thrombosis that determines the occurrence of events such as myocardial infarction or stroke.^R4 Infections may, by activating cytokines and other mediators, predispose to plaque rupture and thrombosis and may accelerate plaque growth, but they are unlikely to operate independently.

The traditional risk factors (age, sex, blood pressure, cholesterol, smoking, and glucose intolerance) explain about half of coronary events and about half of atherosclerotic plaque.^R5 New approaches to the discovery of additional causes of unexplained atherosclerosis, through use of plaque measurement and multiple regression with traditional risk factors, are being applied. This approach has shown that plasma homocyst(e)ine^R6 and a hereditary predisposition to chlamydia infection due to a polymorphism in mannose-binding lectin (a protein involved in resistance to chlamydia^R7 ) are independent predictors of carotid plaque. Undoubtedly, many other new factors will be revealed by such methods to contribute to development and growth of atherosclerotic plaque as well as to atherosclerotic events resulting from plaque rupture and thrombosis.

A key question is whether treating such infections will make a difference^R8 ; a corollary is whether treatment of such infections will need to be chronic, or repeated as patients are reinfected. One thing appears virtually certain: treatment of such infections is unlikely to be the sole answer to atherosclerosis, nor will it eliminate the need to treat other risk factors.

Received July 11, 2000; revision received October 1, 2000; accepted October 27, 2000.

	References

Top Abstract Introduction Subjects and Methods Results Discussion References Introduction  References

 
1. Bachmaier K, Neu N, de la Maza LM, Pal S, Hessel A, Penninger JM. Chlamydia infections and heart disease linked through antigenic mimicry [see comments]. Science. 1999;283:1335–1339.[Abstract/Free Full Text]

2. Abdelmouttaleb I, Danchin N, Ilardo C, Aimone-Gastin I, Angioi M, Lozniewski A, Loubinoux J, Le Faou A, Gueant JL. C-Reactive protein and coronary artery disease: additional evidence of the implication of an inflammatory process in acute coronary syndromes. Am Heart J. 1999;137:346–351.[Medline] [Order article via Infotrieve]

3. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-Reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000;342:836–843.[Abstract/Free Full Text]

4. Hegele RA. The pathogenesis of atherosclerosis. Clin Chim Acta. 1996;246:21–38.[Medline] [Order article via Infotrieve]

5. Spence JD, Barnett PA, Bulman DE, Hegele R. An approach to ascertain probands with a non traditional risk factor for carotid atherosclerosis. Atherosclerosis. 1999;144:429–434.[Medline] [Order article via Infotrieve]

6. Spence JD, Barnett PA, Hegele RA, Marian AJ, Freeman D, Malinow MR. Plasma homocyst(e)ine, but not MTHFR genotype, is associated with variation in carotid plaque area. Stroke. 1999;30:969–973.[Abstract/Free Full Text]

7. Hegele RA, Ban MR, Anderson CM, Spence JD. Infection-susceptibility alleles of mannose-binding lectin are associated with increased carotid plaque area. J Invest Med. 2000;48:198–202.[Medline] [Order article via Infotrieve]

8. Shafran SD, Conley JM. Does chlamydia pneumoniae cause coronary atherosclerosis and should we all take macrolides? Can J Cardiol. 1997;13:1017–1019.[Medline] [Order article via Infotrieve]

This article has been cited by other articles:

				N. P. Tobin, G. T. Henehan, R. P. Murphy, J. C. Atherton, A. F. Guinan, S. W. Kerrigan, D. Cox, P. A. Cahill, and P. M. Cummins Helicobacter pylori-induced inhibition of vascular endothelial cell functions: a role for VacA-dependent nitric oxide reduction Am J Physiol Heart Circ Physiol, October 1, 2008; 295(4): H1403 - H1413. [Abstract] [Full Text] [PDF]

				D.-F. Dai, J.-W. Lin, J.-H. Kao, C.-N. Hsu, F.-T. Chiang, J.-L. Lin, Y.-H. Chou, K.-L. Hsu, C.-D. Tseng, Y.-Z. Tseng, et al. The Effects of Metabolic Syndrome Versus Infectious Burden on Inflammation, Severity of Coronary Atherosclerosis, and Major Adverse Cardiovascular Events J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2532 - 2537. [Abstract] [Full Text] [PDF]

				T W Weiss, H Kvakan, C Kaun, M Prager, W S Speidl, G Zorn, S Pfaffenberger, I Huk, G Maurer, K Huber, et al. No evidence for a direct role of Helicobacter pylori and Mycoplasma pneumoniae in carotid artery atherosclerosis J. Clin. Pathol., November 1, 2006; 59(11): 1186 - 1190. [Abstract] [Full Text] [PDF]

				L. B. Goldstein, R. Adams, M. J. Alberts, L. J. Appel, L. M. Brass, C. D. Bushnell, A. Culebras, T. J. DeGraba, P. B. Gorelick, J. R. Guyton, et al. Primary Prevention of Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline. Circulation, June 20, 2006; 113(24): e873 - e923. [Abstract] [Full Text] [PDF]

				L. B. Goldstein, R. Adams, M. J. Alberts, L. J. Appel, L. M. Brass, C. D. Bushnell, A. Culebras, T. J. DeGraba, P. B. Gorelick, J. R. Guyton, et al. Primary Prevention of Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline. Stroke, June 1, 2006; 37(6): 1583 - 1633. [Abstract] [Full Text] [PDF]

				S. F. Ameriso, A. R. Villamil, C. Zedda, J. C. Parodi, S. Garrido, M. I. Sarchi, M. Schultz, J. Boczkowski, and G. E. Sevlever Heme Oxygenase-1 Is Expressed in Carotid Atherosclerotic Plaques Infected by Helicobacter pylori and Is More Prevalent in Asymptomatic Subjects Stroke, September 1, 2005; 36(9): 1896 - 1900. [Abstract] [Full Text] [PDF]

				M. Diomedi, A. Pietroiusti, M. Silvestrini, B. Rizzato, L. M. Cupini, F. Ferrante, A. Magrini, A. Bergamaschi, A. Galante, and G. Bernardi CagA-positive Helicobacter pylori strains may influence the natural history of atherosclerotic stroke Neurology, September 14, 2004; 63(5): 800 - 804. [Abstract] [Full Text] [PDF]

				B. Ludewig, P. Krebs, and E. Scandella Immunopathogenesis of atherosclerosis J. Leukoc. Biol., August 1, 2004; 76(2): 300 - 306. [Abstract] [Full Text] [PDF]

				M. R. Preusch, A. J. Grau, F. Buggle, C. Lichy, J. Bartel, C. Black, and J. Rudi Association Between Cerebral Ischemia and Cytotoxin-Associated Gene-A-Bearing Strains of Helicobacter pylori Stroke, August 1, 2004; 35(8): 1800 - 1804. [Abstract] [Full Text] [PDF]

				M. Gabrielli, A. Santoliquido, F. Cremonini, V. Cicconi, M. Candelli, M. Serricchio, P. Tondi, R. Pola, G. Gasbarrini, P. Pola, et al. CagA-positive cytotoxic H. pylori strains as a link between plaque instability and atherosclerotic stroke Eur. Heart J., January 1, 2004; 25(1): 64 - 68. [Abstract] [Full Text] [PDF]

				P. J. Lindsberg and A. J. Grau Inflammation and Infections as Risk Factors for Ischemic Stroke Stroke, October 1, 2003; 34(10): 2518 - 2532. [Abstract] [Full Text] [PDF]

				M. Mayr, S. Kiechl, M. A. Mendall, J. Willeit, G. Wick, and Q. Xu Increased Risk of Atherosclerosis Is Confined to CagA-Positive Helicobacter pylori Strains: Prospective Results From the Bruneck Study Stroke, March 1, 2003; 34(3): 610 - 615. [Abstract] [Full Text] [PDF]

				A. Pietroiusti, M. Diomedi, M. Silvestrini, L. M. Cupini, I. Luzzi, M. J. Gomez-Miguel, A. Bergamaschi, A. Magrini, T. Carrabs, M. Vellini, et al. Cytotoxin-Associated Gene-A-Positive Helicobacter pylori Strains Are Associated With Atherosclerotic Stroke Circulation, July 30, 2002; 106(5): 580 - 584. [Abstract] [Full Text] [PDF]

				F. Franceschi, A. R. Sepulveda, A. Gasbarrini, P. Pola, N. G. Silveri, G. Gasbarrini, D. Y. Graham, and R. M. Genta Cross-Reactivity of Anti-CagA Antibodies With Vascular Wall Antigens: Possible Pathogenic Link Between Helicobacter pylori Infection and Atherosclerosis Circulation, July 23, 2002; 106(4): 430 - 434. [Abstract] [Full Text] [PDF]

				R K Singh, A D McMahon, H Patel, C J Packard, B J Rathbone, and N J Samani Prospective analysis of the association of infection with CagA bearing strains of Helicobacter pylori and coronary heart disease Heart, July 1, 2002; 88(1): 43 - 46. [Abstract] [Full Text] [PDF]

				P. B. Gorelick Stroke Prevention Therapy Beyond Antithrombotics: Unifying Mechanisms in Ischemic Stroke Pathogenesis and Implications for Therapy: An Invited Review Stroke, March 1, 2002; 33(3): 862 - 875. [Abstract] [Full Text] [PDF]

				W. A. Ghali, H. Quan, T. E. Feasby, S. F. Ameriso, R. C. Leiguarda, and G. E. Sevlever Helicobacter pylori and Cerebrovascular Disease Response Stroke, August 1, 2001; 32(8): 1936 - 1936. [Full Text] [PDF]

				F. Mach, G. K. Sukhova, M. Michetti, P. Libby, and P. Michetti Influence of Helicobacter pylori Infection During Atherogenesis In Vivo in Mice Circ. Res., January 11, 2002; 90 (1): e1 - e4. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ameriso, S. F. Articles by Spence, J. D. Search for Related Content PubMed PubMed Citation Articles by Ameriso, S. F. Articles by Spence, J. D. Related Collections Pathophysiology Risk Factors Carotid Stenosis Mechanism of atherosclerosis/growth factors